Learn More
Medchemexpress LLC Nabumetone-d3 (BRL14777-d3) | 1216770-08-9 | 98.8% | 1 MG

Supplier: Medchemexpress LLC HYB0559S1MG
Nabumetone-d3 is the deuterium-labeled form of Nabumetone (HY-B0559), an orally active, non-acidic anti-inflammatory agent. It acts as a potent and selective COX-2 inhibitor and is a proagent for its active metabolite, α-Demethylnaproxen (HY-W086896). Nabumetone has been observed to inhibit cancer cell proliferation and reduce gastric ulcers. This compound is intended for research applications, such as a tracer or an internal standard in quantitative analyses like NMR, GC-MS, or LC-MS.
- Deuterium-labeled form of nabumetone.
- Orally active, non-acidic anti-inflammatory agent.
- Potent and selective COX-2 inhibitor.
- Proagent for its active metabolite.
- Inhibits cancer cell proliferation.
- Reduces gastric ulcers.
- Intended for research applications.
- Suitable as a tracer or internal standard in quantitative analyses like NMR, GC-MS, or LC-MS.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.